{"schema_version":"1","generated_at":"2026-10-29T07:32:13.281Z","data_as_of":null,"url":"https://www.findmykol.com/kol/andrew-reikes","json_url":"https://www.findmykol.com/kol/andrew-reikes/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"andrew-reikes","name":"Andrew Reikes","credential":"MD","specialty":"Endocrinology, Diabetes & Metabolism","specialty_raw":"Endocrinology, Diabetes & Metabolism","therapeutic_area":"Endocrinology/Metabolic","therapeutic_areas":["Endocrinology/Metabolic"],"institution":"University of California, Irvine","institution_url":"https://www.findmykol.com/institution/university-of-california-irvine","city":"Orange","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1023198272","openalex":"A5016224324"},"summary":"Andrew Reikes is an Endocrinology/Metabolic physician affiliated with University of California, Irvine. OpenAlex indexes 15 publications with 1,450 citations (h-index 5).","overview":null,"focus":{"indications":[],"research_topics":["Endocrinology/Metabolic"]},"scholarship":{"works_count":15,"cited_by_count":1450,"h_index":5,"latest_activity_year":2025,"emerging":true,"source":"works"},"prescribing":{"data_year":2024,"areas_total":11,"areas_shown":3,"areas":[{"area":"Cardiovascular","share_pct":35.8,"classes_total":9,"classes":[{"class":"Statin","setting":"prescribed","share_pct":15.9,"drugs":[{"name":"Atorvastatin Calcium","share_pct":66},{"name":"Rosuvastatin Calcium","share_pct":23.4},{"name":"Pravastatin Sodium","share_pct":6.4},{"name":"Simvastatin","share_pct":4.1}],"max_beneficiaries":null},{"class":"Calcium channel blocker","setting":"prescribed","share_pct":5.5,"drugs":[{"name":"Amlodipine Besylate","share_pct":100}],"max_beneficiaries":71}]},{"area":"Metabolism & gastrointestinal","share_pct":28.9,"classes_total":12,"classes":[{"class":"Biguanide (metformin)","setting":"prescribed","share_pct":6.1,"drugs":[{"name":"Metformin Hcl","share_pct":55.8},{"name":"Metformin Hcl Er","share_pct":44.2}],"max_beneficiaries":39},{"class":"GLP-1 receptor agonist","setting":"prescribed","share_pct":6,"drugs":[{"name":"Rybelsus","share_pct":36.4},{"name":"Ozempic","share_pct":29.7},{"name":"Trulicity","share_pct":26.7},{"name":"Mounjaro","share_pct":7.2}],"max_beneficiaries":null}]},{"area":"Hormonal (systemic)","share_pct":15,"classes_total":2,"classes":[{"class":"l-Thyroxine","setting":"prescribed","share_pct":14.5,"drugs":[{"name":"Levothyroxine Sodium","share_pct":79.4},{"name":"Synthroid","share_pct":20.6}],"max_beneficiaries":117},{"class":"Parathyroid Hormone Analog","setting":"prescribed","share_pct":0.4,"drugs":[{"name":"Teriparatide","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"funding":{"award_count":1,"fiscal_years":{"first":2024,"last":2024},"rows_total":2,"shown":2,"withheld":0,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"OT2OD036428","title":"All of Us Southern California Consortium (AoUSCC): Engagement, Enrollment, and Retention of Diverse Populations","fiscal_year":2024,"amount_usd":"4000000","organization":"UNIVERSITY OF CALIFORNIA-IRVINE","source_url":"https://reporter.nih.gov/quickSearch/OT2OD036428"},{"project":"OT2OD036428","title":"All of Us Southern California Consortium (AoUSCC): Engagement, Enrollment, and Retention of Diverse Populations","fiscal_year":2024,"amount_usd":"300147","organization":"UNIVERSITY OF CALIFORNIA-IRVINE","source_url":"https://reporter.nih.gov/quickSearch/OT2OD036428"}],"source":"grants"},"publications":{"total":12,"shown":5,"withheld":7,"matched_by":"OpenAlex author record","recent":[{"title":"Trends in Pharmacological Treatment of Patients With New Onset Type 2 Diabetes: Usage Patterns in an Evolving Guideline Landscape","year":2025,"journal":"Journal of Diabetes","source_url":"https://doi.org/10.1111/1753-0407.70108","status":"verified"},{"title":"When AI Writes Back: Ethical Considerations by Physicians on AI-Drafted Patient Message Replies","year":2025,"journal":"arXiv (Cornell University)","status":"verified"},{"title":"Insulin Glargine Utilization and Spending Before and After the First Biosimilar Insulin Glargine: A Real-World Data Study","year":2025,"journal":"Journal of General Internal Medicine","source_url":"https://doi.org/10.1007/s11606-025-09917-5","status":"verified"},{"title":"The Effect of Substituting Water for Artificially Sweetened Beverages on Glycemic and Weight Measures in People With Type 2 Diabetes: The Study of Drinks With Artificial Sweeteners (SODAS), a Randomized Trial","year":2025,"journal":"Diabetes Care","source_url":"https://doi.org/10.2337/dc25-1516","status":"verified"},{"title":"The effect of substituting water for artificially sweetened beverages on glycemic and weight measures in people with type 2 diabetes: The Study of Drinks with Artificial Sweeteners (SODAS), a randomized trial","year":2025,"source_url":"https://doi.org/10.2337/figshare.30559481.v1","status":"verified"}],"source":"works"},"contact":{"address_1":"UCI MEDICAL CENTER","address_2":"101 THE CITY DRIVE SOUTH","city":"Orange","state":"CA","zip":"92868","phone":"714-456-8978","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1023198272","source":"identity"},"similar":[{"name":"Susan O’Brien","slug":"susan-obrien","institution":"University of California, Irvine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/susan-obrien","json_url":"https://www.findmykol.com/kol/susan-obrien/profile.json"},{"name":"Steven Potkin","slug":"steven-potkin","institution":"University of California, Irvine","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/steven-potkin","json_url":"https://www.findmykol.com/kol/steven-potkin/profile.json"},{"name":"Stefan Ciurea","slug":"stefan-ciurea","institution":"University of California, Irvine","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stefan-ciurea","json_url":"https://www.findmykol.com/kol/stefan-ciurea/profile.json"},{"name":"Farshid Dayyani","slug":"farshid-dayyani","institution":"University of California, Irvine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/farshid-dayyani","json_url":"https://www.findmykol.com/kol/farshid-dayyani/profile.json"},{"name":"Yousef Saleh Khader","slug":"yousef-khader","institution":"Jordan University of Science and Technology","url":"https://www.findmykol.com/kol/yousef-khader","json_url":"https://www.findmykol.com/kol/yousef-khader/profile.json"},{"name":"Jens Juul Holst","slug":"jens-holst","institution":"University of Copenhagen","url":"https://www.findmykol.com/kol/jens-holst","json_url":"https://www.findmykol.com/kol/jens-holst/profile.json"},{"name":"Victor Montori","slug":"victor-montori","institution":"Mayo Clinic","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/victor-montori","json_url":"https://www.findmykol.com/kol/victor-montori/profile.json"},{"name":"Christos Mantzoros","slug":"christos-mantzoros","institution":"Harvard Medical School","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/christos-mantzoros","json_url":"https://www.findmykol.com/kol/christos-mantzoros/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":7}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-05-14","provider_certified":"2026-05-14","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}